Botulinum Toxin Injection for Sialorrhea in Cerebral Palsy
NCT06101160 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 61
Last updated 2023-10-27
Summary
A 100 units of botulinum toxin was injected in both parotid and submandibular glands for children (2 - 12 years) with incapacitating sialorrhea in juvenile cerebral palsy patients and they are followed up for 1 year
Conditions
- Sialorrhea
Interventions
- DRUG
-
onaBoNT-A
injection under ultrasonography
Sponsors & Collaborators
-
Cairo University
lead OTHER
Eligibility
- Min Age
- 4 Years
- Max Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-30
- Primary Completion
- 2022-05-01
- Completion
- 2023-04-30
Countries
- Egypt
Study Locations
More Related Trials
-
Evaluation of the Efficacy of the Injection of Botulinum Toxin A vs Scopolamine Patches in the Treatment of Drooling in Children With Cerebral Palsy
NCT03616067 ·Status: TERMINATED ·Phase: PHASE3
-
Botulinum Toxin (BOTOX) for Cerebral Palsy
NCT00060957 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Repeated Botulinum Toxin Injections in Children With Cerebral Palsy
NCT05295563 ·Status: COMPLETED
-
Study of Intramuscular Injections of OnabotulinumtoxinA to Assess Change in Disease Activity in Pediatric Participants With Spasticity Associated With Cerebral Palsy
NCT06150729 ·Status: COMPLETED
-
Effect of Botulinum Toxin on Muscles of Children With Cerebral Palsy
NCT02853240 ·Status: COMPLETED ·Phase: NA
-
BOTOX® Treatment in Pediatric Lower Limb Spasticity
NCT01603628 ·Status: COMPLETED ·Phase: PHASE3
-
BOTOX® Treatment in Pediatric Upper Limb Spasticity
NCT01603602 ·Status: COMPLETED ·Phase: PHASE3
-
Spread And Effectiveness Of Botulinum Neurotoxin A In Spastic Equinus In Cerebral Palsy
NCT01276015 ·Status: COMPLETED ·Phase: PHASE4
-
Toxin Treatment for Amyotrophic Lateral Sclerosis (ALS) Related Sialorrhea
NCT01551940 ·Status: COMPLETED ·Phase: PHASE2
-
BOTOX® Open-Label Treatment in Pediatric Lower Limb Spasticity
NCT01603641 ·Status: COMPLETED ·Phase: PHASE3
-
BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity
NCT01603615 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Botulinum Toxin on Selective Motor Control and Pain in Diplegic Cerebral Palsy
NCT06583343 ·Status: COMPLETED ·Phase: PHASE4
-
Safety on Switching Between Different Botulinum Toxin-A
NCT03234413 ·Status: COMPLETED
-
Muscle Elastography in Spastic Cerebral Palsy
NCT03112434 ·Status: COMPLETED
-
Botulinum Toxin-A for Sialorrhoea Treatment in Asian Adults With Neurological Diseases
NCT02425176 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Botulinum Toxin and Saliva Management in Tracheotomised Patients
NCT00973999 ·Status: WITHDRAWN ·Phase: PHASE2
-
Improvement After Botulinum Toxin Injections to the Arms in Children With Cerebral Palsy
NCT00549471 ·Status: TERMINATED ·Phase: PHASE4
-
Sarcopenia and Osteopenia in Individuals With Cerebral Palsy and Influences After Botulinum Neurotoxin Type A Injection
NCT05207124 ·Status: UNKNOWN
-
Does Botulinum Toxin A Make Walking Easier in Children With Cerebral Palsy?
NCT02546999 ·Status: COMPLETED ·Phase: PHASE4
-
Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
NCT02002884 ·Status: COMPLETED ·Phase: PHASE3
-
Early Use of Botulinum Toxin in Spasticity Post Stroke.
NCT01882556 ·Status: COMPLETED ·Phase: PHASE2
-
Botulinum Toxin Efficiency on Spasticity of Rectus Femoris and Semitendinosus Muscles as Functional Agonist and Antagonist Muscles
NCT00133861 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Adult Spasticity Registry of OnabotulinumtoxinA Treatment
NCT01930786 ·Status: COMPLETED
-
Effect of Botulinum Toxin Injection Guided by Ultrasound Combined With Balloon Localization on Cricopharyngeal Achalasia
NCT06213662 ·Status: RECRUITING ·Phase: NA
-
OnabotulinumtoxinA Treatment in Adult Patients With Upper Limb Spasticity
NCT02145676 ·Status: TERMINATED ·Phase: PHASE3